These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23084587)
1. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma. Ryu HS; Chung JH; Lee K; Shin E; Jing J; Choe G; Kim H; Xu X; Lee HE; Kim DG; Lee H; Jang JJ Hum Pathol; 2012 Dec; 43(12):2360-70. PubMed ID: 23084587 [TBL] [Abstract][Full Text] [Related]
2. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma. Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma. Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794 [TBL] [Abstract][Full Text] [Related]
4. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330 [TBL] [Abstract][Full Text] [Related]
5. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma. Su MC; Hsu C; Kao HL; Jeng YM Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303 [TBL] [Abstract][Full Text] [Related]
6. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642 [TBL] [Abstract][Full Text] [Related]
7. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624 [TBL] [Abstract][Full Text] [Related]
8. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma. Balsano C; Conti B; Arciello M Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009 [No Abstract] [Full Text] [Related]
9. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma. Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842 [TBL] [Abstract][Full Text] [Related]
11. Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Aishima S; Taguchi K; Terashi T; Matsuura S; Shimada M; Tsuneyoshi M Mod Pathol; 2003 Oct; 16(10):1019-27. PubMed ID: 14559985 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression. Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859 [TBL] [Abstract][Full Text] [Related]
14. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Zhao P; Lu Y; Zhong M; Liu L; Li B Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray. Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440 [TBL] [Abstract][Full Text] [Related]
16. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma. Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797 [TBL] [Abstract][Full Text] [Related]
17. The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis. Meng F; Han Y; Staloch D; Francis T; Stokes A; Francis H Hepatology; 2011 Nov; 54(5):1718-28. PubMed ID: 21793031 [TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. Gu MJ; Choi JH J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361 [TBL] [Abstract][Full Text] [Related]
19. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Aishima S; Fujita N; Mano Y; Kubo Y; Tanaka Y; Taketomi A; Shirabe K; Maehara Y; Oda Y Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073 [TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]